Chr. Hansen

Novozymes and Chr. Hansen to Merge

Danish companies Novozymes and Chr. Hansen have agreed to merge, in a move they termed a perfect match that will create a global leader in biosolutions.

Top-Feature

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.